Amedeo Smart

Free Medical Literature Service

 

Amedeo

Hepatitis C
  Free Subscription

Articles published in
Transplantation
    February 2024
  1. THULUVATH PJ, Amjad W, Russe-Russe J, Li F, et al
    The Lower Survival in Patients With Alcoholism and Hepatitis C Continues in the DAA Era.
    Transplantation. 2024 Feb 23. doi: 10.1097/TP.0000000000004953.
    >> Share

  2. PATEL SS, Kim JI, Stewart DE, Segev DL, et al
    Organ Nonutilization Following Revision to the Public Health Service Donor Risk Criteria for HIV, HCV, or HBV Transmission.
    Transplantation. 2024 Feb 16. doi: 10.1097/TP.0000000000004929.
    >> Share

    October 2023
  3. BOYLE M, Van Oudtsh CVR
    P8.1: Kidney acceptance from HCV NAT positive donors - Improving Organ utilization in NSW, Australia.
    Transplantation. 2023;107.
    >> Share

    May 2023
  4. SHAH KK, Wyld M, Hedley JA, Waller KMJ, et al
    Cost-effectiveness of Kidney Transplantation From Donors at Increased Risk of Blood-borne Virus Infection Transmission.
    Transplantation. 2023 May 26. doi: 10.1097/TP.0000000000004632.
    >> Share

    November 2022
  5. MYERS B, Bekki Y, Kozato A, Crismale JF, et al
    DCD Hepatitis C Virus-positive Donor Livers Can Achieve Favorable Outcomes With Liver Transplantation and Are Underutilized.
    Transplantation. 2022 Nov 7. pii: 00007890-990000000-00240.
    >> Share

    October 2022
  6. WOOLLEY AE, Gandhi AR, Jones ML, Kim JJ, et al
    The Cost-effectiveness of Transplanting Hearts From Hepatitis C-infected Donors Into Uninfected Recipients.
    Transplantation. 2022 Oct 27. doi: 10.1097/TP.0000000000004378.
    >> Share

    May 2022
  7. SIBULESKY L, Leca N, Limaye AP, Ramasamy B, et al
    Survival Benefit in Older Patients Transplanted With Viremic Hepatitis C Positive Kidneys When Compared With High KDPI Kidneys.
    Transplantation. 2022 May 27. pii: 00007890-990000000-00059.
    >> Share

    April 2022
  8. BEKKI Y, Crismale JF, Myers B, Schiano TD, et al
    Varying Utilization Rates but Superior Outcomes in Liver Transplantation From Hepatitis C-positive Donors in the US: An Analysis of the OPTN/UNOS Database.
    Transplantation. 2022 Apr 6. pii: 00007890-990000000-00025.
    >> Share

  9. GUPTA G, Devarakonda T, Sharma A, Miles M, et al
    Ultrashort Duration Prophylaxis for Hepatitis C Donor Positive to Recipient Negative Simultaneous Kidney/Pancreas Transplants.
    Transplantation. 2022;106:e234-e235.
    >> Share

    February 2022
  10. COTTER TG, Charlton M
    The Authors' Reply: Geographic Variation in the Utilization of HCV-viremic Donors Into HCV-negative Recipients.
    Transplantation. 2022;106:e166.
    >> Share

  11. BEKKI Y, Myers B
    Geographic Variation in the Utilization of HCV-viremic Donors into HCV-negative Recipients.
    Transplantation. 2022;106:e165.
    >> Share

  12. WALLER KMJ, De La Mata NL, Rosales BM, Hedley JA, et al
    Characteristics and Donation Outcomes of Potential Organ Donors Perceived to Be at Increased Risk for Blood-borne Virus Transmission: An Australian Cohort Study 2010-2018.
    Transplantation. 2022;106:348-357.
    >> Share

    July 2021
  13. RICHTER BI, Parent B, Lonze BE
    The Moral Necessity to Increase Access to HCV+ Transplants With Early Treatment for HCV Naive Patients.
    Transplantation. 2021 Jul 22. pii: 00007890-900000000-95189.
    >> Share

    May 2021
  14. MUTHUKUMAR T, Akat KM, Yang H, Schwartz JE, et al
    Serum MicroRNA Transcriptomics and Acute Rejection or Recurrent Hepatitis C Virus in Human Liver Allograft Recipients: A Pilot Study.
    Transplantation. 2021 May 11. pii: 00007890-900000000-95253.
    >> Share

    February 2021
  15. CALABRESE DR
    Ribavirin to the Rescue: Natural Killer Cell Function After Hepatitis C Virus Treatment in Liver Transplant Recipients.
    Transplantation. 2021 Feb 12. pii: 00007890-900000000-95359.
    >> Share

  16. YOELI D, Choudhury RA, Moore HB, Sauaia A, et al
    Are Hepatitis C Positive Female Liver Transplant Recipients Still at Increased Risk for Graft Failure? Re-Examining the Disparity in the Modern Era of Direct Acting Antiviral Agents.
    Transplantation. 2021 Feb 11. pii: 00007890-900000000-95364.
    >> Share

  17. HUCKABY LV, Seese LM, Handzel R, Wang Y, et al
    Center-level Utilization of Hepatitis C Virus Positive Donors for Orthotopic Heart Transplantation.
    Transplantation. 2021 Feb 8. doi: 10.1097/TP.0000000000003674.
    >> Share

    January 2021
  18. FUJISAKI T, Mikami T, Kuno T, Moss N, et al
    Effect of Hepatitis C Virus Infection on Heart Transplants in the Current Era.
    Transplantation. 2021 Jan 25. pii: 00007890-900000000-95404.
    >> Share

    December 2020
  19. ADENUGBA A, Hornung M, Weigand K, Peschel G, et al
    Ribavirin Improves NK Cell IFNgamma Response During Sofosbuvir-based DAA Therapy in CV-infected Liver Transplant Recipients.
    Transplantation. 2020 Dec 29. pii: 00007890-900000000-95432.
    >> Share

    October 2020
  20. NGUYEN T, Sise ME, Delgado C, Williams W, et al
    Race, Education, and Gender Disparities in Transplantation of Kidneys from Hepatitis C Viremic Donors.
    Transplantation. 2020 Oct 29. doi: 10.1097/TP.0000000000003511.
    >> Share

    January 2020
  21. GORGEN A, Galvin Z, Huang AC, Vinaixa C, et al
    The Impact of Direct Acting Antivirals on Overall Mortality and Tumoral Recurrence in Patients with Hepatocellular Carcinoma Listed for Liver Transplantation.: An International Multicenter Study.
    Transplantation. 2020 Jan 16. doi: 10.1097/TP.0000000000003115.
    >> Share

    August 2019
  22. WEEKS SR, Luo X, Haugen CE, Ottmann SE, et al
    Delayed graft function in simultaneous liver kidney transplantation.
    Transplantation. 2019 Aug 8. doi: 10.1097/TP.0000000000002908.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016